Hasmukh Chudgar & family
$7.6B
Born
Sep 19, 1933
Age
92
Source of Wealth
Pharmaceuticals
Residence
Ahmedabad,
Citizenship
India
Marital Status
Married
Children
3
Education
- Low profile Hasmukh Chudgar founded generics maker Intas Pharmaceuticals in 1977.
- Chudgar has long handed over operations to his sons Nimish and Binish, who run the $3.5 billion (revenue) company.
- In August 2025, Intas Pharma acquired biosimilar company Udenyca from California-based Coherus Life Sciences for $558 million.
- The company's portfolio includes an affordable drug to treat breast cancer called Eleftha, which is similar to Roche's Herceptin.
- In 2022, the Abu Dhabi Investment Authority bought a 3% stake in Intas from Temasek.
- Chudgar's third son Urmish heads the company's biopharma business and is a haematologist-oncologist.
- The company's biggest markets are Europe and India.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|